Evidence map›Paper›PMID 30460411›Full record

ReviewJournal of cancer research and clinical oncology2019

Surgical staging in endometrial cancer.

Maria Luisa Gasparri, Donatella Caserta, Pierluigi Benedetti Panici, Andrea Papadia, Michael D Mueller

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of cancer research and clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Sentinel Lymph Node Biopsy in Surgical Staging for High-Risk Groups of Endometrial Carcinoma Patients.International journal of environmental research and public health · 2022
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Sentinel lymph node intraoperative analysis in endometrial cancer.Journal of cancer research and clinical oncology · 2020
    Article
  12. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Maria Luisa GasparriDepartment of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, Switzerland. marialuisa.gasparri@uniroma1.it.ORCID http://orcid.org/0000-0002-9482-9527
Donatella CasertaSurgical and Medical Department of Translational Medicine, Sapienza University of Rome, Rome, Italy.
Pierluigi Benedetti PaniciDepartment of Gynecological-Obstetrical Sciences and Urological Sciences, Sapienza University of Rome, Rome, Italy.
Andrea PapadiaDepartment of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, Switzerland.
Michael D MuellerDepartment of Obstetrics and Gynecology, University Hospital of Bern and University of Bern, Bern, Switzerland.
University of Bern · CHSapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In several malignancies, it has been demonstrated that the lymph nodal status is the most important pathologic factor affecting prognosis and giving the indication to further adjuvant treatment. The surgical assessment of the lymph nodal status in endometrial cancer is debated since 30 years. Recently, the sentinel lymph node mapping is rapidly gaining clinical acceptance in endometrial cancer. The adoption of Indocyanine Green as a safe and user friendly tracer for sentinel lymph node mapping increased the speed to which this procedure is getting applied in clinical practice. As a consequence of this rapid growth, several fundamental questions have been raised and are still debatable. In this manuscript, we discuss the importance of a known pathological lymph nodal status, the technique of the sentinel lymph node mapping with the reported false negative rates and detection rates according to the different tracers adopted, and the clinical scenarios in which a sentinel lymph node mapping could be employed.

Indexed as

Sentinel Lymph Node BiopsyEndometrial NeoplasmsFemaleFluorescenceHumansIndocyanine GreenLymphatic MetastasisNeoplasm StagingReproducibility of ResultsIndocyanine GreenEndometrial cancerFluorescenceIndocyanine greenLaparoscopySentinel lymph node mapping

Identifiers

PMID30460411
PMCPMC11810401
OpenAlexW2900769799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.